Key Takeaways Wedbush upgraded Snowflake as the analysts predicted that the artificial intelligence software era is ...

Wedbush has assumed coverage of Voyager Therapeutics (VYGR) with an outperform rating, highlighting the company’s TRACER ...

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

Gerber has grown skeptical of Musk's other ventures in recent years, and has said previously that his side projects are ...

News of an investigation by the Federal Trade Commission into Microsoft (NASDAQ:MSFT) is "not a worry" with Chairwoman Lina ...

Wedbush has an outperform rating on Apple's stock heading into the holiday season and a 12-month price target of $300, that's about 28% above its current price. It's the highest price target among the ...

We recently published a list of 15 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Power needs for artificial intelligence and cloud computing are expanding so rapidly that some data center campuses may use ...

Wedbush notes that in the past two weeks Kioxia filed for an IPO and SanDisk released its 10-12B, telling investors that data from these ...

For some, Black Friday kicks off the holiday shopping season, a period of time that Apple (NASDAQ:AAPL) is heavily dependent ...

The EV maker’s stock gained 3.7% on Friday, leaving the shares ahead nearly 40% for the year and giving it a market value of ...

IMAX Corp.'s shares have climbed 71.2% in 2024, and analyst firm Wedbush sees more upside ahead for the high-end ...